The Government of NCT of Delhi on August 17, 2026, issued an advisory against displaying or publicising unrealistic, exaggerated, false, misleading or vague claims regarding discounts or prices of medicines.
The following has been stated: -
•The Drug Control Department, Government of NCT of Delhi, has advised all licensed pharmacies and medical stores to refrain from displaying or publicising unrealistic, exaggerated, false, misleading or vague claims regarding discounts or prices of medicines.
•The advisory follows the Kerala High Court judgment dated June 19, 2026, which upheld regulatory action against misleading discount boards while recognising that selling medicines below MRP is permissible.
•Pharmacies must ensure that discounts offered are genuine, transparent, verifiable through sale bills and purchase records, and that medicines are procured from authorised drug-licensed distributors or wholesalers.
•The advisory aims to protect consumers, promote ethical pharmaceutical sales and prevent misleading commercial practices. Chemist associations have been requested to sensitise their members regarding compliance.
The detailed notification is given in the document below.
[Notification No.: F.No. DCD-15019/12/2026-EB-DRUGS CONTROL DEPARTMENT (Comp. No. E 397122)]
